Results 61 to 70 of about 101,889 (202)

All That Bleeds Is Not Infliximab-Refractory Ulcerative Colitis

Canadian Journal of Gastroenterology, 2009
The role of biological agents in moderate to severe ulcerative colitis has been shown to be effective in the induction of clinical remission. However, the role of infliximab therapy for induction of remission in patients with fulminant colitis is ...
JK Law, B Salh, EM Yoshida
doaj   +1 more source

Optimization of the indications for allogeneic stem cell transplantation in Acute Myeloid Leukemia based on interactive diagnostic strategies

, 2011
The indications for allogeneic stem cell transplantation (SCT) in Acute Myeloid Leukemia (AML) represent a real challenge due to the clinical and genetic heterogeneity of the disorder.
Hartwig, Maite, Zander, Axel R., Haferlach, Torsten, Fehse, Boris, Bacher, Ulrike, Kröger, Nicolaus   +5 more
core   +1 more source

Effectiveness of Remission Induction Strategies for Early Rheumatoid Arthritis: a Systematic Literature Review

, 2019
PURPOSE OF REVIEW: To review the effectiveness of remission induction strategies compared to single csDMARD-initiating strategies according to current guidelines in early RA.
Jacobs, J. W.G., Bijlsma, J. W.J., Verhoeven, M. M.A., van Laar, J. M., Welsing, P. M.J., Lafeber, F. P.J.G., Tekstra, J.   +6 more
core   +1 more source

Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study [PDF]

Background: There are scarce data available on upadacitinib in children with Crohn's disease (CD). Aim: To evaluate the effectiveness and safety of upadacitinib as an induction therapy in paediatric CD. Methods: This was a multicentre retrospective study
Tzivinikos, Christos, Yogev, Dotan, Kang, Ben, Kolho, Kaija‐Leena, Bramuzzo, Matteo, Hackl, Lukas, Olbjørn, Christine, Rungoe, Christine, Cohen, Shlomi, Hradsky, Ondrej, Henderson, Paul, Wlazlo, Magdalena, Spencer, Elizabeth A., Suskind, David L., Conrad, Máire A., Uhlig, Holm H., Mitrova, Katarina, Urlep, Darja, Shouval, Dror S., Dolinger, Michael T., Kelsen, Judith R., Pujol‐Muncunill, Gemma, D'Arcangelo, Giulia, Gasparetto, Marco   +23 more
core   +2 more sources

No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML 10 and 12 trials

, 2005
Fetal liver tyrosine kinase 3 (FLT3) internal tandem duplications (ITDs) are powerful adverse prognostic indicators for relapse in acute myelold leukemia (AML) but the most efficacious therapy for FLT3/ ITD+ patients is currently unknown.
Wheatley, Keith, Burnett, Alan Kenneth, Gale, RE, Hills, Robert Kerrin, Kottaridis, Panagiotis D., Linch, David C., Burnett, AK, Kottaridis, PD, Srirangan, S, Hills, Robert, Hills, R, Srirangan, Sivatharsini, Wheatley, K, Gale, Rosemary E., Linch, DC   +14 more
core   +1 more source

Efficacy of Adalimumab in Korean Patients with Crohn’s Disease

Gut and Liver, 2016
Background/Aims : Adalimumab is effective for both remission induction and the maintenance of Crohn’s disease (CD) in Western countries. We evaluated the efficacy of adalim-umab in the conventional step-up treatment approach for CD in Korea. Methods : We
doaj   +1 more source

Cyclosporine A for induction of remission in severe ulcerative colitis

Cochrane Database of Systematic Reviews, 2005
Ulcerative colitis (UC) is characterized by a life-long chronic course with remissions and exacerbations. Approximately 15% of patients have a severe attack requiring hospitalization at some time during their illness. These patients are traditionally treated with intravenous corticosteroids, with a response rate of approximately 60%.
Shibolet, Oren, Regushevskaya, Elena, Brezis, Mayer, Soares‐Weiser, Karla   +3 more
openaire   +2 more sources

Certolizumab pegol for induction of remission in Crohn's disease

Cochrane Database of Systematic Reviews, 2017
Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract, and immune response modulation is the main treatment strategy to induce remission in active CD. Certolizumab pegol (CZP) is a tumor necrosis factor-alfa (TNF-α) inhibitor which regulates impaired immune response.The primary objectives were to evaluate the efficacy and
Hajime, Yamazaki, Ryuhei, So, Katsuyoshi, Matsuoka, Taku, Kobayashi, Shinichiro, Shinzaki, Minoru, Matsuura, Shinji, Okabayashi, Yuki, Kataoka, Yasushi, Tsujimoto, Toshi A, Furukawa, Norio, Watanabe   +10 more
openaire   +4 more sources

Infection during remission induction in childhood leukaemia [PDF]

Archives of Disease in Childhood, 1980
We have analysed our experience in the management of suspected infection in a group of 221 children with acute leukaemia undergoing induction of first remission. Patients with suspected infection received early empirical antibiotic therapy with cephalothin and gentamicin pending results of bacteriological investigations.
J M, Chessells, A D, Leiper
openaire   +2 more sources

Infliximab for medical induction of remission in Crohn's disease

Cochrane Database of Systematic Reviews, 2023
Infliximab is a monoclonal antibody that binds and neutralises tumour necrosis factor-alpha (TNF-α), which is present in high levels in the blood serum, mucosa and stool of people with Crohn's disease.To evaluate the benefits and harms of infliximab alone or in combination with another agent for induction of remission in Crohn's disease compared to ...
Gordon, Morris, Sinopoulou, Vassiliki, Akobeng, Anthony K, Radford, Shellie J, Eldragini, Mohsen, Darie, Ana-Maria, Moran, Gordon William   +6 more
openaire   +2 more sources